Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2019 Jan;24(1):1-19.
doi: 10.1007/s10147-018-1351-y. Epub 2018 Oct 5.

Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer

Yasuhiko Ebina  1 , Mikio Mikami  2 , Satoru Nagase  3 , Tsutomu Tabata  4 , Masanori Kaneuchi  5 , Hironori Tashiro  6 , Masaki Mandai  7 , Takayuki Enomoto  8 , Yoichi Kobayashi  9 , Hidetaka Katabuchi  6 , Nobuo Yaegashi  10 , Yasuhiro Udagawa  11 , Daisuke Aoki  12
Affiliations
Practice Guideline

Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer

Yasuhiko Ebina et al. Int J Clin Oncol. 2019 Jan.

Abstract

The Japan Society of Gynecologic Oncology (JSGO) Guidelines 2017 for the Treatment of Uterine Cervical Cancer are for the purpose of providing standard treatment strategies for cervical cancer, indicating treatment methods currently considered appropriate for cervical cancer, minimizing variances in treatment methods among institutions, improving the safety of treatment and prognosis of diseases, reducing the economic and psychosomatic burden of patients by promoting performance of appropriate treatment, and enhancing mutual understanding between patients and healthcare professionals. The guidelines were prepared through consensus of the JSGO Guideline Committee, based on careful review of evidence gathered through the literature searches and in view of the medical health insurance system and actual clinical practice situations in Japan. The guidelines comprise eight chapters and five algorithms. The main features of the 2017 revision are as follows: (1) evidence was collected using a search formula and with cooperation of the Japan Library Association. The bibliographical search formula was placed at the end of the book; (2) regarding clinical questions (CQs) where evidence or clinical inspection in Japan was lacking, opinions of the Guidelines Committee were described as "proposals for future directions"; (3) cervical intraepithelial neoplasia (CIN) 3 and adenocarcinoma in situ (AIS) were treated as a cervical precancerous lesion; (4) the CQs of endoscopic surgery, radical trachelectomy, and sentinel node biopsy were newly added in Chapter 3, "primary treatment for stage IB-II cervical cancer"; and (5) the CQ about hormone replacement therapy after cancer treatment was newly established. Each recommendation is accompanied by a classification of recommendation categories based on the consensus reached by the Guideline Committee members. Here, we present the English version of the JSGO Guidelines 2017 for the Treatment of Uterine Cervical Cancer.

Keywords: Chemotherapy; Clinical practice guidelines; Irradiation; Recurrence; Surgery; Uterine cervical cancer.

PubMed Disclaimer

References

    1. Cancer. 1999 Apr 1;85(7):1537-46 - PubMed
    1. Int J Gynecol Cancer. 2000 Jul;10(4):305-312 - PubMed
    1. Gynecol Oncol. 2001 Jul;82(1):11-6 - PubMed
    1. Int J Gynecol Cancer. 1998 Jan;8(1):23-26 - PubMed
    1. Int J Gynecol Cancer. 1993 Jul;3(4):193-198 - PubMed

Publication types